Systemic Anti Cancer Therapy (SACT) Patient Information leaflets.
If you cannot find the leaflet you require, please contact our patient information manager Leigh Porter for assistance.
- EcarboF 377
- EcarboX 374
- ECF 4
- ECF 362
- EC-T
- ECX 277
- Encorafenib and Binimetinib
- Encorafenib and Cetuximab A1294
- (Enhertu®) Trastuzumab deruxtecan
- Entrectinib A1254
- Enzalutamide 690
- Epirubicin, Carboplatin, Paclitaxel, Cyclophosphamide and Pembrolizumab 547, A1023, A1600 and A1162
- Epirubicin, Cyclophosphamide and Paclitaxel A1023, A1601, A1228, A1229
- Erlotinib (Tarceva) 449
- Eribulin 647
- Etoposide 338
- Etoposide, Doxorubicin and Cisplatin chemotherapy 670
- EOX 276
- Everolimus 484
- Paclitaxel 402,242 & 662
- Palbociclib 949
- Panitumumab with oxaliplatin, 5 fluorouracil and folinic acid (OxMdG) A1047
- Pembrolizumab and Lenvatinib A1553
- Pemetrexed
- Phesgo
- Pixantrone
- Pazopanib
- Pemetrexed and carboplatin 570
- Pembrolizumab 836
- Pembrolizumab, Paclitaxel, Carboplatin, Epirubicin and Cyclophosphamide, 547, A1023, A1600, A1162
- Pemetrexed and cisplatin 354
- Princess of Wales
- Procarbazine, lomustine and vincristine 95 (PCV)
- PICC line - Securacath